Acute Lymphoblastic Leukemia
Gabriella Leggio
Gabriella Leggio, Student, Department of Biology, Stonehill College, Easton (Massachusetts) U.S.
Manuscript received on May 21, 2016. | Revised Manuscript received on May 22, 2016. | Manuscript published on June 25, 2016. | PP: 19-25 | Volume-4 Issue-5, June 2016. | Retrieval Number: E1110054516
Open Access | Ethics and Policies | Cite
© The Authors. Published By: Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Abstract: Leukemia is a cancer of the blood and bone marrow due to increased amounts of abnormal or immature white blood cells. A type of leukemia that occurs in the early forms of lymphocytes is called acute lymphoblastic leukemia (ALL). Diagnosis is made by the confirmation of different tests that are preformed. Once diagnosed, ALL is aggressively treated following an oncologist’s treatment plan. There are a few different options for treatment of ALL. However, the prognosis for acute lymphoblastic leukemia is very poor. There is current research being conducted for new treatments and agents in order to cure patients with acute lymphoblastic leukemia (ALL).
Keywords: Leukemia, ALL, leukemia, Once diagnosed, confirmation